Asia Infectious Diseases

• Asia-Pacific Lyophilized Injectable Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)   

  Dec 05, 2022  |  Published by: The Insight Partners  |  USD 3,000

  ... Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others) The APAC lyophilized injectable market is expected to grow ... Read More

• Global Immunoassays Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type (Reagents & Kits, Analyzers/Instruments, and Software & Services), Application (Cardiology, Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Technology (Radio immunoassay (RIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions (North America, Asia Pacific, Europe, Latin America, Middle East and Africa)

  Nov 01, 2022  |  Published by: Ken Research  |  USD 4,500

  ... Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions ... Read More

• Global Pharmaceutical Drug Delivery Market, By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Other Drug Delivery); By Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Diseases, Auto Immune Diseases and Others); By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028

  Aug 05, 2022  |  Published by: BlueWeave Consulting  |  USD 4,450

  ... Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Diseases, Auto Immune Diseases and Others); By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & ... Read More

• Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027

  Jun 06, 2022  |  Published by: MarketsandMarkets  |  USD 4,950

  ... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More

• Asia Pacific Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)

  Apr 05, 2022  |  Published by: The Insight Partners  |  USD 3,000

  ... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Asia Pacific monoclonal antibodies market is expected to reach US$ 44,729.7 million by 2028 from US$ 18,344.5 ... Read More

• Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, DPT, Yellow Fever, Typhoid, Japanese Encephalitis, Measles Mumps & Rubella, Rabies, Polio, Influenza, Varicella & Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel)

  Mar 21, 2022  |  Published by: The Insight Partners  |  USD 4,550

  ... Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel) The travel vaccines market is projected to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021. It is estimated to grow ... Read More

• Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  Feb 03, 2022  |  Published by: Coherent Market Insights  |  USD 4,500

  ... and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Lyophilization or freeze drying is the process in which the water content ... Read More

• Global Pneumonia Therapeutics Market; By Therapeutics (Prevention Vaccine, Treatment Drugs and Oxygen Therapy), By Drug Class (Antibacterial Drugs (Macrolide, Quinolones, and Others), Antiviral Drugs and Antifungal Drugs), By Age Group (Paediatric, Adult and Geriatric), By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP] and Ventilator-associated Pneumonia [VAP]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, the Asia-Pacific, the Middle-East & Africa, and Latin America)Trend Analysis, Competitive Market Share & Forecast, 2018-2028

  Jan 19, 2022  |  Published by: BlueWeave Consulting  |  USD 4,250

  ... Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP] and Ventilator-associated Pneumonia [VAP]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, the Asia-Pacific, the Middle-East & Africa, and Latin ... Read More

• COVID-19 Global Economic Impact March 2020 Update

  Mar 23, 2020  |  Published by: Freedonia Group  |  USD 450

  ... the predictions made in February 2020, before Covid 19 cases began spreading outside of China. Updated annual growth rates for real Gross Domestic Product (GDP) are given for the following: World North America United States ... Read More

< prev 1 2 3 next >